Author:
Taylor N S,Thorne G M,Bartlett J G
Abstract
Clostridium difficile was shown to produce a toxin which could be biochemically separated from the previously described cytotoxin of the same organism. The two proteins differ in biological activity and physical properties. Antiserum prepared to the second toxin does not neutralize the biological activity of the cytotoxin, and immunological cross-reactivity could not be demonstrated. However, some relationship may exist between the two toxins, since the newly described toxin degrades on polyacrylamide electrophoresis into two molecules, one of which appears to migrate with the band of purified cytotoxin. We suggest that this newly described toxin be designated toxin A until its primary biological activity and physical relationship to cytotoxin is determined. This toxin is active in biological assays of enteric disease and may play an important role in C. difficile-induced colitis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference28 articles.
1. Aswell M. E. M. Ehrich R. L. Van Tassell C.-C. Tsai V. Holdeman and T. W. Wilkins. 1979. Characterization and comparison of Clostridium difficile and other clostridial toxins p. 272-275. In D. Schlessinger (ed.) Microbiology-1979. American Society for Microbiology Washington D.C.
2. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia;Bartlett J. G.;N. Engl. J. Med.,1978
3. The role of Clostridium difficile in antibiotic-associated pseudomembranous colitis;Bartlett J. G.;Gastroenterology,1978
4. Clindamycim-associated colitis due to toxin-producing species of Clostridium in hamsters;Bartlett J. G.;J. Infect. Dis.,1977
5. Campbell D. H. T. S. Garvey N. E. Cremer and D. H. Sussdorf. 1970. Isolation of rabbit antibodies and their subunits p. 189-191. In D. Campbell (ed.) Methods in Immunology 2nd ed. W. A. Benjamin Inc. New York.
Cited by
296 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clostridioides difficile
infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options;Clinical Microbiology Reviews;2024-06-13
2. Engineering probiotic bacteria to express tcdB antigen as an oral vaccine carrier against Clostridium difficile infection;Egyptian Pharmaceutical Journal;2024-02-24
3. Increased intestinal permeability and downregulation of absorptive ion transporters
Nhe3
,
Dra
, and
Sglt1
contribute to diarrhea during
Clostridioides difficile
infection;Gut Microbes;2023-06-23
4. Toxin-mediated downregulation of absorptive ion transporters NHE3, DRA, and SGLT1 in the colon contributes to diarrhea associated withClostridioides difficileinfection;2022-11-13
5. Secreted Glycosyltransferase RsIA_GT of Rhizoctonia solani AG-1 IA Inhibits Defense Responses in Nicotiana benthamiana;Pathogens;2022-09-09